This study is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial of 100 mg doxycycline BID for 72 weeks for emphysema in people living with HIV.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Subhashini Sellers
Medicine-Pulmonary
Clinical or Medical
Interventional
HIV/AIDS
Immune System/Infections
Lungs and Breathing
22-2713
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
